Is DD a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for DuPont de Nemours (DD) rests on Life after the Qnity spin-off: With Qnity Electronics now trading on its own, DuPont shareholders who held through the spin own two stocks instead of one. The bear case rests on separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. Analysts covering it publish targets from $145.00 to $186.00 against a $130.45 price, so even the professionals disagree by 25% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
DuPont de Nemours is a diversified specialty chemicals and materials company. After the 2019 split of DowDuPont into three companies (Dow, DuPont, Corteva), DuPont retained the specialty materials businesses. In 2024 it announced a plan to separate into three companies (Electronics, Water and Industrial); the plan was later narrowed, and the step that happened was the spin-off of the electronics business as Qnity Electronics, which DuPont announced as complete in late 2025. DuPont now describes itself as focused on healthcare, water, construction and industrial markets, and its best-known products include Tyvek protective and medical packaging materials. The separation reset the numbers. Yahoo Finance data as of October 2026 shows trailing revenue of about $7.0 billion (versus roughly $12-13 billion for the pre-spin company), operating margin near 14%, and GAAP net income of only about $306 million because 2025 carried separation-related losses. On an adjusted basis earnings are much stronger: second-quarter 2026 revenue was about $1.82 billion, up about 4% year over year, and adjusted EPS of $1.88 beat the roughly $1.76 consensus, the fourth beat in a row. The stock trades near 16.5x forward earnings, pays $0.60 per quarter ($2.40 a year, about a 1.8% yield), and reports third-quarter results on November 3, 2026. Headquartered in Wilmington, Delaware. Lori Koch has been CEO since 2024.
The bull case: what would have to be true for $186.00
The most optimistic published target on DD is $186.00, +42.6% from the $130.45 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Life after the Qnity spin-off.
With Qnity Electronics now trading on its own, DuPont shareholders who held through the spin own two stocks instead of one. The remaining DD is smaller (market value around $17.8 billion, trailing revenue about $7 billion) and less exposed to the semiconductor cycle. The open question is whether a focused materials company earns a better multiple than the old conglomerate; at about 16.5x forward earnings it currently trades like a mid-cycle industrial.
2. Healthcare and protective materials.
Tyvek and related materials are used in medical packaging, protective garments and building wrap, and healthcare is one of the four markets DuPont now names as core. These businesses tend to have steadier demand than electronics, which supports margins and the dividend, though they lack the growth rate investors attached to the semiconductor segment.
3. Water business resilience.
Water remains one of DuPont's named markets, spanning water treatment, desalination, and ion exchange applications. Demand is structural and grows steadily with global infrastructure investment, and this unit is a large part of why the remaining company is pitched as a less cyclical portfolio than the old DuPont.
4. Earnings recovery and capital returns.
Analysts expect adjusted EPS of about $7.26 in 2026 and about $8.00 in 2027, against trailing GAAP EPS near $3.69 that still includes separation costs. Free cash flow of roughly $1.84 billion over the trailing year funds a $2.40 annual dividend. Delivery against those estimates, starting with the November 3 report (consensus EPS about $1.89 on $1.85 billion of revenue), decides whether the forward multiple compresses further or re-rates.
The bear case: what would have to be true for $145.00
The most pessimistic published target is $145.00, +11.2% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks DuPont de Nemours is worth if the risks below bite instead of the drivers above.
Separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. The remaining businesses are exposed to cyclical construction and industrial demand. Analysts have been trimming expectations in October 2026: JPMorgan downgraded the stock to neutral with a $145 target, and RBC and Citigroup cut targets to $160 and $162. Shares are about 17% below their 52-week high of roughly $158. Holders who kept Qnity shares from the spin carry separate semiconductor-cycle risk in that position.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding DD already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on DD
17 analysts cover DD, with an average target of $165.47 (+26.8% against $130.45) and a split of 14 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the DD forecast and price target page.
How is DD valued? (as of October 2026)
Snapshot for DD as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM, post-Qnity): ~$7.0 billion, +~4% yoy in Q2 2026
- Q2 2026 adjusted EPS: $1.88 vs ~$1.76 expected
- Operating margin (TTM): ~14%
- Net income (TTM): ~$306 million GAAP (separation costs); EPS ~$3.69
- P/E trailing / forward: ~35.8x / ~16.5x
- Dividend: $0.60 quarterly, ~1.8% yield
- Free cash flow (TTM): ~$1.84 billion
- Market cap: ~$17.8 billion (share price ~$131.90)
The trailing P/E of about 36x is distorted by separation charges; on forward estimates DuPont trades near 16.5x, a typical specialty-materials multiple now that the electronics business trades separately as Qnity. The average analyst target of about $165 sits above the price, though several firms cut targets in October 2026 ahead of the November 3 third-quarter report.
How do you decide if DD is a buy?
Rather than asking whether DD is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold DD indirectly through an index or sector ETF before adding more.
What would change your mind on DD
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Life after the Qnity spin-off stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the DD stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about DD against your real portfolio and see your actual exposure before deciding.
Investing in DuPont de Nemours with AI
Connect the broker you already use and ask Walnut's AI how DD fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is DD a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Life after the Qnity spin-off, with revenue (ttm, post-qnity) at ~$7.0 billion, +~4% yoy in Q2 2026. The bear case rests on separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. Analysts covering it are spread from $145.00 to $186.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell DD?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $145.00, +11.2% from the $130.45 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for DD?
+
Life after the Qnity spin-off. With Qnity Electronics now trading on its own, DuPont shareholders who held through the spin own two stocks instead of one. The most optimistic analyst target on DD is $186.00, +42.6% from the $130.45 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for DD?
+
Separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. The remaining businesses are exposed to cyclical construction and industrial demand. Analysts have been trimming expectations in October 2026: JPMorgan downgraded the stock to neutral with a $145 target, and RBC and Citigroup cut targets to $160 and $162. Shares are about 17% below their 52-week high of roughly $158. Holders who kept Qnity shares from the spin carry separate semiconductor-cycle risk in that position. The most pessimistic published target is $145.00, +11.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does DuPont de Nemours do?
+
Diversified specialty materials. Separating into three companies (Electronics, Water, Industrial) by 2026.
What would have to change for DD to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Life after the Qnity spin-off) stalling in the reported numbers rather than in the narrative, the risk above (separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What is DuPont's ticker symbol?
+
DD, listed on NYSE. Officially DuPont de Nemours, Inc. The current entity is the successor to the 2019 DowDuPont split (which also created Dow and Corteva). In late 2025 it completed the spin-off of its electronics business, which now trades separately as Qnity Electronics; DD itself kept its ticker.
Who are DuPont's competitors?
+
Depends on segment. Water: Veolia, Xylem, Pentair, Ecolab. Specialty, healthcare and industrial materials: 3M, Honeywell, Eastman Chemical, plus many niche product-specific competitors. Semiconductor materials rivals such as Entegris and Merck KGaA now compete with Qnity, the spun-off electronics company, rather than with DD.
What is the DuPont separation?
+
DuPont announced in 2024 a plan to separate into three independent public companies (Electronics, Water and Industrial). The plan was later narrowed, and the electronics business was spun off as Qnity Electronics, a separation DuPont announced as complete in late 2025. The remaining DuPont describes itself as focused on healthcare, water, construction and industrial markets.
Walnut is informational, not investment advice, and gives no verdict on DD. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature DD
DD is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.